View : 330 Download: 102

Full metadata record

DC Field Value Language
dc.contributor.author손경복-
dc.date.accessioned2019-07-31T16:30:01Z-
dc.date.available2019-07-31T16:30:01Z-
dc.date.issued2019-
dc.identifier.issn1744-8603-
dc.identifier.otherOAK-25032-
dc.identifier.urihttp://dspace.ewha.ac.kr/handle/2015.oak/250331-
dc.description.abstractBackground: Recently, interest in compulsory licensing of pharmaceuticals has been growing regardless of a country's income- level. We aim to investigate the use of compulsory licensing as a legitimate part of the patent system and tool for the government to utilize by demonstrating that countries with a mature patent system were more likely to utilize compulsory licensing of pharmaceuticals. Methods: We used a multivariate logistic model to regress attempts to issue compulsory licensing on the characteristics of the intellectual property system, controlling for macro context variables and other explanatory variables at a country level. Results: A total 139 countries, selected from members of the World Trade Organization, were divided into a CL-attempted group (N = 24) and a non-CL-attempted group (N = 115). An attempt to issue compulsory licensing was associated with population (+) and a dummy variable for other regions, including Europe and North America (-). After controlling for macro context variables, mature intellectual property system was positively associated with attempting compulsory licensing. Conclusions: Our study provided evidence of an association between attempting compulsory licensing and matured patent systems. This finding contradicts our current understanding of compulsory licensing, such as compulsory licensing as a measure to usurp traditional patent systems and sometimes diametrically opposed to the patent system. The findings also suggest a new role of compulsory licensing in current patent systems: compulsory licensing could be a potential alternative or complement to achieve access to medicines in health systems through manufacturing and exporting patented pharmaceuticals. © 2019 The Author(s).-
dc.languageEnglish-
dc.publisherBioMed Central Ltd.-
dc.subjectAccess to medicines-
dc.subjectCompulsory licensing-
dc.subjectIntellectual property-
dc.subjectPatent system-
dc.titleImportance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: A cross-sectional analysis-
dc.typeArticle-
dc.relation.issue1-
dc.relation.volume15-
dc.relation.indexSCIE-
dc.relation.indexSSCI-
dc.relation.indexSCOPUS-
dc.relation.journaltitleGlobalization and Health-
dc.identifier.doi10.1186/s12992-019-0485-7-
dc.identifier.wosidWOS:000473182400001-
dc.identifier.scopusid2-s2.0-85068484027-
dc.author.googleSon K.-B.-
dc.date.modifydate20190827100823-


qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

BROWSE